Establishment of a central post-stroke pain model using global cerebral ischaemic mice

Journal of Pharmacy and Pharmacology

Volumn 65, Issue 4, 2013, Pages 615-620

  Tamiya, Shigeyuki ^a   Yoshida, Yuki ^a   Harada, Shinichi ^a   Nakamoto, Kazuo ^a   Tokuyama, Shogo ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

Author keywords

bilateral carotid artery occlusion; central post stroke pain; cerebral ischaemia; hyperalgesia; primary afferent neuron

Indexed keywords

AFFERENT NERVE GROUP 1; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; CELL DEATH; CENTRAL POSTSTROKE PAIN; CONTROLLED STUDY; ELECTROSTIMULATION; HIPPOCAMPAL CA3 REGION; HYPERALGESIA; LATENT PERIOD; MALE; MECHANICAL STIMULATION; MOUSE; NERVE FIBER C; NONHUMAN; PAIN; PAIN THRESHOLD; PASSIVE AVOIDANCE; PYKNOTIC CELL DEATH; THERMAL STIMULATION;

ANIMALS; BRAIN ISCHEMIA; CAROTID ARTERIES; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; HINDLIMB; HOT TEMPERATURE; HYPERALGESIA; MALE; MICE; MICE, INBRED STRAINS; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; NEURONS, AFFERENT; PAIN THRESHOLD; PAIN, INTRACTABLE; PHYSICAL STIMULATION; STROKE; SURGICAL INSTRUMENTS;

EID: 84875275620     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12007     Document Type: Article

References (24)

1. Li J, et al,. Neuroprotective effects of adenosine monophosphate- activated protein kinase inhibition and gene deletion in stroke. Stroke 2007; 38: 2992-2999.
2. Kumar B, et al,. Central poststroke pain: a review of pathophysiology and treatment. Anesth Analg 2009; 108: 1645-1657.
3. Hackett ML, et al,. Frequency of depression after stroke: a systematic review of observational studies. Stroke 2005; 36: 1330-1340.
4. Klehmet J, et al,. Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience 2009; 158: 1184-1193.
5. Boivie J, et al,. Central post-stroke pain-a study of the mechanisms through analyses of the sensory abnormalities. Pain 1989; 37: 173-185.
6. Pickering AE, et al,. Analgesia in conjunction with normalisation of thermal sensation following deep brain stimulation for central post-stroke pain. Pain 2009; 147: 299-304.
7. Longa EZ, et al,. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke 1989; 20: 84-91.
8. Bacigaluppi M, et al,. Animal models of ischemic stroke. Part two: modeling cerebral ischemia. Open Neurol J 2010; 4: 34-38.
9. Walker EJ, Rosenberg GA,. TIMP-3 and MMP-3 contribute to delayed inflammation and hippocampal neuronal death following global ischemia. Exp Neurol 2009; 216: 122-131.
10. Kumaran D, et al,. Benzamide protects delayed neuronal death and behavioural impairment in a mouse model of global cerebral ischemia. Behav Brain Res 2008; 192: 178-184.
11. Liu PK, et al,. Damage, repair, and mutagenesis in nuclear genes after mouse forebrain ischemia-reperfusion. J Neurosci 1996; 16: 6795-6806.
12. Takami K, et al,. Aβ and Aδ but not C-fibres are involved in stroke related pain and allodynia: an experimental study in mice. J Pharm Pharmacol 2011; 63: 452-456.
13. Harada S, et al,. Ameliorating effect of hypothalamic brain-derived neurotrophic factor against impaired glucose metabolism after cerebral ischemic stress in mice. J Pharmacol Sci 2012; 118: 109-116.
14. Tanabe M, et al,. Role of descending noradrenergic system and spinal alpha2-adrenergic receptors in the effects of gabapentin on thermal and mechanical nociception after partial nerve injury in the mouse. Br J Pharmacol 2005; 144: 703-714.
15. Matsumoto M, et al,. Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin. J Pharmacol Exp Ther 2006; 318: 735-740.
16. Kuner R,. Central mechanisms of pathological pain. Nat Med 2010; 16: 1258-1266.
17. Morimoto S, et al,. Spinal mechanism underlying the antiallodynic effect of gabapentin studied in the mouse spinal nerve ligation model. J Pharmacol Sci 2012; 118: 455-466.
18. Huang J, et al,. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006; 66: 232-245.
19. Katims JJ, et al,. New screening device for assessment of peripheral neuropathy. J Occup Med 1986; 28: 1219-1221.
20. Masson EA, et al,. Current perception thresholds: a new, quick, and reproducible method for the assessment of peripheral neuropathy in diabetes mellitus. Diabetologia 1989; 32: 724-728.
21. Masson EA, Boulton AJ,. The Neurometer: validation and comparison with conventional tests for diabetic neuropathy. Diabet Med 1991; 8: spec No S63-S66.
22. Pitei DL, et al,. The value of the Neurometer in assessing diabetic neuropathy by measurement of the current perception threshold. Diabet Med 1994; 11: 872-876.
23. Liu S, et al,. Quantitative assessment of differential sensory nerve block after lidocaine spinal anesthesia. Anesthesiology 1995; 82: 60-63.
24. Tay B, et al,. Quantitative assessment of differential sensory blockade after lumbar epidural lidocaine. Anesth Analg 1997; 84: 1071-1075.